CEO Interview

Abingdon Health PLC

15 March 2024

 

Abingdon Health plc

("Abingdon" or "the Company")

CEO interview on the Proactive Investors Platform

York, U.K. 15 March 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract development and manufacturing organization (CDMO), is pleased to share a recent interview with Chris Yates, CEO of Abingdon, on the Proactive Investors Platform.

Within this video Chris provides an overview of the financial and operational highlights from Abingdon interim results which were announced on the 14 March 2024.

Click on the link below to watch:

https://www.proactiveinvestors.co.uk/companies/news/1043260/abingdon-health-ceo-discusses-strong-interim-results-robust-pipeline-and-growth-strategy-1043260.html

Enquiries

Abingdon Health plc	www.abingdonhealth.com/investors/
Chris Yates, Chief Executive Officer
Chris Hand, Non-Executive Chairman
Singer Capital Markets (Sole Broker and Nominated Adviser)	Tel: [phone]
Peter Steel, Alex Bond (Corporate Finance)
Tom Salvesen (Corporate Broking)

About Abingdon Health plc

Abingdon Health is a leading lateral flow contract development and manufacturing organisation (CDMO) offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. 

Abingdon Health's Abingdon Simply Test range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

 

END